Evidence map›Paper›PMID 39767388›Full record

ArticleInternational journal of environmental research and public health2024

Gulshara Abildinova, Tamara Vochshenkova, Alisher Aitkaliyev, Aizhan Abildinova, Valeriy Benberin, Anna Borovikova, Nazira Bekenova, Balzhan Kassiyeva

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Journal of diabetes and metabolic disorders · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gulshara AbildinovaDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.
Tamara VochshenkovaDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.ORCID 0000-0003-0935-6217
Alisher AitkaliyevDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.ORCID 0009-0002-9624-2663
Aizhan AbildinovaMunicipal Polyclinic N° 9, Astana 010000, Kazakhstan.
Valeriy BenberinDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.
Anna BorovikovaDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.ORCID 0000-0002-6161-4765
Nazira BekenovaDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.ORCID 0000-0002-3312-3299
Balzhan KassiyevaDepartment of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP14871581
6 · The paper itself

Abstract

The gut microbiota plays a fundamental role in the host's energy metabolism and the development of metabolic diseases such as arterial hypertension, insulin resistance, and atherosclerosis. Our study aimed to investigate the potential role of the gut microbiota in arterial hypertension among individuals of the Kazakh population without insulin resistance. 16S rRNA gene sequencing of faecal samples from 197 Kazakh subjects was performed. Preliminary binary comparisons of the faecal microbiota composition depending on the presence of arterial hypertension and insulin resistance revealed statistically significant differences in the abundance of the

Indexed as

BacillotaFecesGastrointestinal MicrobiomeHypertensionInsulin ResistanceAdultAgedChinaFemaleHumansKazakhstanMaleMiddle AgedRNA, Ribosomal, 16SRNA, Ribosomal, 16Sarterial hypertensiongut microbiotainsulin resistancephylum Firmicutes

Identifiers

PMID39767388
PMCPMC11675478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.